ArticleJournal of Brown hospital medicine2025
Diffuse Large B Cell Lymphoma Presenting as a Cardiac Mass Complicated by Atrial Arrhythmia.
Article in Journal of Brown hospital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A case of diffuse large B-cell lymphoma with cardiac tumor presenting tachycardia-bradycardia syndrome associated with atrial fibrillation.Journal of cardiology cases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac involvement in diffuse large B-cell lymphoma (DLBCL) is uncommon and often presents with nonspecific symptoms, such as chest pain and dyspnea, which can lead to challenges in diagnosis. Cardiac lymphomas most often arise in the right atrium or the pericardium, and can thus result in tachyarrhythmias, pericardial effusions, and heart failure symptoms, all of which can further complicate clinical management. Diagnosis typically requires comprehensive imaging such as cardiac magnetic resonance imaging (MRI) or positron emission tomography-computed tomography (PET-CT), as transthoracic echocardiography (TTE) alone is limited in the diagnosis of intracardiac masses, as well as tissue biopsy for histopathological confirmation. Treatment typically involves systemic chemotherapy, though outcomes are generally poor, as cardiac involvement is generally a late manifestation of DLBCL. This case underscores the importance of early recognition, need for comprehensive imaging and tissue diagnosis, and multidisciplinary care in managing cardiac lymphoma, as well as the challenges associated with refractory disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.